Kinnersley N - Search Results

1

Efzofitimod for the Treatment of Pulmonary Sarcoidosis.

Culver DA, Aryal S, Barney J, Hsia CCW, James WE, Maier LA, Marts LT, Obi ON, Sporn PHS, Sweiss NJ, Shukla S, Kinnersley N, Walker G, Baughman R. Culver DA, et al. Among authors: kinnersley n. Chest. 2023 Apr;163(4):881-890. doi: 10.1016/j.chest.2022.10.037. Epub 2022 Nov 8. Chest. 2023. PMID: 36356657 Free PMC article. Clinical Trial.

2

Exposure-response analyses of efzofitimod in patients with pulmonary sarcoidosis.

Walker G, Adams R, Guy L, Chandrasekaran A, Kinnersley N, Ramesh P, Zhang L, Brown F, Niranjan V. Walker G, et al. Among authors: kinnersley n. Front Pharmacol. 2023 Oct 3;14:1258236. doi: 10.3389/fphar.2023.1258236. eCollection 2023. Front Pharmacol. 2023. PMID: 37854715 Free PMC article.

3

SARS-CoV-2 infection among healthcare workers in India: Limitations of the case-control investigation.

Niranjan V, Kinnersley N. Niranjan V, et al. Among authors: kinnersley n. Indian J Med Res. 2020 Jul & Aug;152(1 & 2):143-144. doi: 10.4103/ijmr.IJMR_2360_20. Indian J Med Res. 2020. PMID: 32773426 Free PMC article. No abstract available.

4

The current state of Bayesian methods in medical product development: survey results and recommendations from the DIA Bayesian Scientific Working Group.

Natanegara F, Neuenschwander B, Seaman JW Jr, Kinnersley N, Heilmann CR, Ohlssen D, Rochester G. Natanegara F, et al. Among authors: kinnersley n. Pharm Stat. 2014 Jan-Feb;13(1):3-12. doi: 10.1002/pst.1595. Epub 2013 Sep 11. Pharm Stat. 2014. PMID: 24027093

5

Use of historical control data for assessing treatment effects in clinical trials.

Viele K, Berry S, Neuenschwander B, Amzal B, Chen F, Enas N, Hobbs B, Ibrahim JG, Kinnersley N, Lindborg S, Micallef S, Roychoudhury S, Thompson L. Viele K, et al. Among authors: kinnersley n. Pharm Stat. 2014 Jan-Feb;13(1):41-54. doi: 10.1002/pst.1589. Epub 2013 Aug 5. Pharm Stat. 2014. PMID: 23913901 Free PMC article. Review.

6

Structured approach to the elicitation of expert beliefs for a Bayesian-designed clinical trial: a case study.

Kinnersley N, Day S. Kinnersley N, et al. Pharm Stat. 2013 Mar-Apr;12(2):104-13. doi: 10.1002/pst.1552. Epub 2013 Jan 21. Pharm Stat. 2013. PMID: 23335494

7

Bayesian fitting of a logistic dose-response curve with numerically derived priors.

Huson LW, Kinnersley N. Huson LW, et al. Among authors: kinnersley n. Pharm Stat. 2009 Oct-Dec;8(4):279-86. doi: 10.1002/pst.348. Pharm Stat. 2009. PMID: 18819118

8

Clinical benefits with oseltamivir in treating influenza in adult populations : results of a pooled and subgroup analysis.

Singh S, Barghoorn J, Bagdonas A, Adler J, Treanor J, Kinnersley N, Ward P. Singh S, et al. Among authors: kinnersley n. Clin Drug Investig. 2003;23(9):561-9. doi: 10.2165/00044011-200323090-00002. Clin Drug Investig. 2003. PMID: 17535069

9

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

Nicholson KG, Aoki FY, Osterhaus AD, Trottier S, Carewicz O, Mercier CH, Rode A, Kinnersley N, Ward P. Nicholson KG, et al. Among authors: kinnersley n. Lancet. 2000 May 27;355(9218):1845-50. doi: 10.1016/s0140-6736(00)02288-1. Lancet. 2000. PMID: 10866439 Clinical Trial.

10

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.

Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, Riff D, Singh S, Kinnersley N, Ward P, Mills RG. Treanor JJ, et al. Among authors: kinnersley n. JAMA. 2000 Feb 23;283(8):1016-24. doi: 10.1001/jama.283.8.1016. JAMA. 2000. PMID: 10697061 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page